Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Duchenne Muscular Dystrophy

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

Arkansas Children's Hospital, Little Rock, Arkansas, United States
Contact: Study coordinator (Aravindhan Veerapandiyan, Dr) · aveerapandiyan@uams.edu · 501-364-1850
Contact: Principal Investigator (Aravindhan Veerapandiyan, Dr)
Rare Disease Research LLC, Atlanta, Georgia, United States
Contact: Study coordinator (Scott Batchelor, Dr) · sbatchelor@rarediseaseresearch.com · 404-782-8239
Contact: Principal Investigator (Scott Batchelor, Dr)
Istiklal Hospital/ Clinical Research Unit, Amman, Jordan
Contact: Study coordinator (Muath Alqurashi, Dr) · drmuathalqurashi@yahoo.com
Contact: Principal Investigator (Muath Alqurashi, Dr)
The Specialty Hospital (TSH)/ Advanced Clinical Center, Amman, Jordan
Contact: Study coordinator (Mai Bader, Dr) · dr.mai.bader@hotmail.com
Contact: Principal Investigator (Mai Bader, Dr)
Oxford Children's Hospital, Oxford University Hospitals NHS Foundation Trust, Headington, Oxford, United Kingdom
Contact: Study coordinator (Laurent Servais, MD, PhD) · Laurent.Servais@ouh.nhs.uk · 01865 227503
Contact: Principal Investigator (Laurent Servais, MD, PhD)

מובילי המחקר